Daniel T Scavilla

CIK 1642439 · View on SEC EDGAR ↗

Insider

First SEC filing: May 15, 2015 · Latest: May 26, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 45 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

45 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 21, 2024 GMED S 10b5-1 130,000 $85.00 $11,050,000 0 Direct -100.00% Disposed 3.8% (price as of 2026-08-20)
Nov. 6, 2024 GMED S 10b5-1 60,000 $80.02 $4,801,200 0 Direct -100.00% Disposed 10.2% (price as of 2026-08-20)
July 2, 2021 GMED S 10b5-1 400 $78.97 $31,588 0 Direct -100.00% Disposed 11.7% (price as of 2026-08-20)
July 2, 2021 GMED S 10b5-1 99,600 $78.41 $7,809,636 400 Direct -99.60% Disposed 12.5% (price as of 2026-08-20)
May 21, 2020 GMED S 10b5-1 100,000 $55.09 $5,509,000 0 Direct -100.00% Disposed 60.1% (price as of 2026-08-20)
April 10, 2018 GMED S 10b5-1 31,250 $50.00 $1,562,500 0 Direct -100.00% Disposed 76.4% (price as of 2026-08-20)
April 10, 2018 GMED S 10b5-1 50,540 $50.00 $2,527,000 0 Direct -100.00% Disposed 76.4% (price as of 2026-08-20)
April 9, 2018 GMED S 10b5-1 18,210 $50.00 $910,500 0 Direct -100.00% Disposed 76.4% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 11, 2026 XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP Common Stock (3,555) — — 3,555 Acquired
March 4, 2026 XRAY Stock Option (Right to Buy) Common Stock (2,066,600) $15.46 March 4, 2036 2,066,600 Acquired
Aug. 8, 2025 XRAY Stock Option (Right to Buy) Common Stock (1,102,600) $12.96 Aug. 8, 2035 1,102,600 Acquired
Jan. 23, 2025 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (140,000) $92.42 Jan. 23, 2035 140,000 Acquired
Nov. 21, 2024 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $43.58 Jan. 22, 2029 80,000 Disposed
Nov. 21, 2024 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (50,000) $43.77 Jan. 22, 2028 50,000 Disposed
Nov. 6, 2024 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (30,000) $43.77 Jan. 22, 2028 30,000 Acquired
Nov. 6, 2024 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (30,000) $26.27 Jan. 30, 2027 30,000 Acquired
Jan. 26, 2024 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (140,000) $53.75 Jan. 26, 2034 140,000 Acquired
Oct. 10, 2023 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (10,000) $53.02 Sept. 1, 2033 10,000 Acquired
Jan. 26, 2023 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (100,000) $75.18 Jan. 26, 2033 100,000 Acquired
April 21, 2022 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (60,000) $79.00 April 21, 2032 60,000 Acquired
Jan. 27, 2022 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (40,000) $63.68 Jan. 27, 2032 40,000 Acquired
July 2, 2021 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (50,000) $26.27 Jan. 30, 2027 50,000 Disposed
July 2, 2021 GMED Stock Option (Right to buy Class A Common Stock) Class A Common Stock (50,000) $25.52 Jan. 25, 2026 50,000 Disposed
Jan. 14, 2021 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (50,000) $65.05 Jan. 14, 2031 50,000 Acquired
May 21, 2020 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (68,750) $25.52 Jan. 25, 2026 68,750 Disposed
May 21, 2020 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (31,250) $25.40 April 8, 2025 31,250 Disposed
Jan. 22, 2020 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $53.27 Jan. 22, 2030 80,000 Acquired
Jan. 22, 2019 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $43.58 Jan. 22, 2029 80,000 Acquired
April 10, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (31,250) $25.52 Jan. 25, 2026 31,250 Disposed
April 10, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (50,540) $25.40 April 8, 2025 50,540 Disposed
April 9, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (18,210) $25.40 April 8, 2025 18,210 Disposed
Jan. 22, 2018 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $43.77 Jan. 22, 2028 80,000 Acquired
Jan. 30, 2017 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (80,000) $26.27 Jan. 30, 2027 80,000 Acquired
Jan. 25, 2016 GMED Stock Option (Right to Buy Class A Common Stock) Class A Common Stock (150,000) $25.52 Jan. 25, 2026 150,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
May 15, 2015 GMED Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (100,000) 100,000 Direct
May 14, 2015 GMED Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (100,000) 100,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

XRAY

CEO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $431,753 $1,079,315 $3,484,488 $3,221,523 $437,150 — $105,910 $8,760,139

GMED

CEO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $284,616 — — — — — $25,678 $5,316,939
2024 $481,077 — — $2,936,886 $1,404,150 — $36,547 $4,858,660
2023 $463,500 $150,000 — $2,896,394 $1,021,500 — $32,980 $4,564,374

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.